Negatively regulating mechanism of Sirpα1 in hepatocellular carcinoma: An experimental study

Hepatobiliary and Pancreatic Diseases International

Volumn 5, Issue 2, 2006, Pages 246-251

  Qin, Jian Min ^a   Yan, He Xin ^a   Liu, Shu Qin ^a   Wan, Xing Wang ^a   Zeng, Jin Zhang ^a   Cao, Hui Fang ^a   Qiu, Xiu Hua ^a   Wu, Meng Chao ^a   Wang, Hong Yang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Effective mechanism; Hepatocellular carcinoma; Signal regulatory protein alphal

Indexed keywords

ANTIBIOTIC G 418; BETA CATENIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; FAS ANTIGEN; REGULATOR PROTEIN; SIGNAL REGULATORY PROTEIN ALPHA 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MITOSIS INHIBITION; PLASMID; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANTIGENS, DIFFERENTIATION; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; PROBABILITY; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33744811153     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Wu MC. Clinical research advances in primary liver cancer. World J Gastroenterol 1998;4:323-326.
2. Tang ZY. Schmtd advances in clinical research of hepatocellular carcinoma in China. World J Gastroenterol 1998;4 (Suppl 2):4-8.
3. Xu HY, Yang YL, Guan XL, Song G, Jiang AM, Shi LJ. Expression of regulating apoptosis gene and apoptosis index in primary liver cancer. World J Gastroenterol 2000;6:721-724.
4. Feitelson MA, Sun B, Satiroglu NL, Liu J, Pan J, Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002; 21:2593-2604.
5. Liu LX, Jiang HC, Zhu AL, Zhou J, Wang XQ, Wu M. Gene expression profiles in liver cancer and normal liver tissues. World J Gastroenterol 2000; 6 (Suppl 3):85-89.
6. Kharitonenkov A, Chen ZJ, Sures I, Wang H, Schilling J, Ullrich A. A family of protein, that inhibit signaling through tyrosine kinase receptors. Nature 1997;386:181-186.
7. Yamao T, Matozaki K, Amano K, Matsuda Y, Takahashi N, Ochi F, et al. Mouse and human SHPS-1: molecular cloning of cDNAs and chromosomal localization of genes. Biochem. Biophys. Res Commun 1997;231:61-67.
8. Bennett AM, Tang TL, Sugimoto S, Walsh CT, Neel BG. Protein tyrosine phosphatase SHPTP2 couples platelet derived growth factor receptor β to ras. Proc Natl Acad Sci 1994;91: 7335-7339.
9. Li B, Wang H, Chen Z, Wu M. Expression and significance of signal-regulatory protein alpha in hepatocellular carcinoma. Zhonghua Zhong Liu Zazhi 1998;5:345-347.
10. Li B, Wang H, Chen Z, Wu M. The association between signal-regulatory protein alpha and hepatocellular carcinoma. Zhonghua Yi Xue Zazhi 1999;79:268-271.
11. Johnson NL, Gardner AM, Diener KM, Lange-Carter CA, Gleavy J, Jarpe MB, et al. Signal transduction pathways regulated by mitogen-activated/ extracellular response kinase kinase kinase induce cell death. J Biol Chem 1996;271:3229-3237.
12. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000;21:485-495.
13. Baker SJ. Modulation of life and death by the TNF receptor superfunily. Oncogene 1998;17:3261-3269.
14. Hunter T. Oncoprotein networks. Cell 1997;88:333-340.
15. Foo SY, Nolan GP. NF-kappaB to the rescue: RELs, apoptosis and cellular transformation. Trends Genet 1999;15:229-235.
16. Hinz M, Krappmanno D, Eichten A, Heder A, Scheidereit C, Strauss M. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transtion. Mol Cell Biol 1999;19:2690-2698.
17. Kaltschmidt B, Kaltschmidt C, Hehner SP, Droge W, Schmitz ML. Repression of NF-kappaB impairs Hela cell proliferation by functional interference with cell cycle checkpoint regulators. Oncogene 1999;18:3213-3225.
18. Otsuka G, Nagaya T, Saito K, Mizuno M, Yoshida J, Seo H. Inhibition of nuclear factor-kappaB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells. Cancer Res 1999;59: 4446-4452.
19. Peifer M. β-catenin as oncogene: the smoking gun. Science 1997;275:1752-1753.
20. Ihara A, Koizumi H, Hashizume R, Uchikoshi T. Expression of epithelial cadherin and α- and β-catenin in nontumoral livers and hepatocellular carcinomas. Hepatology 1996;23: 1441-1447.
21. Higashitsuji H, Itoh K, Nagao T, Dawson S, Fujita J. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic aiikyrin-repeat protein overexpressed in hepatomas. Nature Med 2000;1:96-99.
22. Fu XY, Wang HY, Tan L, Liu SQ, Cao HF, Wu MC. Overexpression of P28/ gankyrin in human hepatocellular carcinoma and its clinical significance. World J Gastroenterol 2002;8:638-643.
23. Qin JM, Yan HX, Wan XW, Liu SQ, Zeng JZ, Cao HF, et al. Effects of signal regulatory protein α1 on proliferation of hepatocellular carcinoma; a preliminary study. Hepatobiliary Pancreat Dis Int 2005;4:244-248.